NDC 68788-7283

bupropion

Bupropion Hydrochloride

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Bupropion Hydrochloride.

Product ID68788-7283_3970ec44-2c55-4b14-840c-d7454a7160a0
NDC68788-7283
Product TypeHuman Prescription Drug
Proprietary Namebupropion
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2014-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA202304
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength200 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68788-7283-1

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7283-1)
Marketing Start Date2019-10-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7283-6 [68788728306]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

NDC 68788-7283-9 [68788728309]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

NDC 68788-7283-1 [68788728301]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

NDC 68788-7283-2 [68788728302]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

NDC 68788-7283-8 [68788728308]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

NDC 68788-7283-3 [68788728303]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-17

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE200 mg/1

Pharmacological Class

  • Aminoketone [EPC]
  • Dopamine Uptake Inhibitors [MoA]
  • Increased Dopamine Activity [PE]
  • Increased Norepinephrine Activity [PE]
  • Norepinephrine Uptake Inhibitors [MoA]

NDC Crossover Matching brand name "bupropion" or generic name "Bupropion Hydrochloride"

NDCBrand NameGeneric Name
68001-264bupropionbupropion
68382-353bupropionbupropion
68382-354bupropionbupropion
68788-7249bupropionbupropion
68788-9255bupropionbupropion
70518-1644bupropionbupropion
71335-0801bupropionbupropion
71335-0785bupropionbupropion
0615-8262bupropionbupropion
43547-288bupropionbupropion
43547-289bupropionbupropion
43547-290bupropionbupropion
50090-3854bupropionbupropion
50436-0289bupropionbupropion
55700-644bupropionbupropion
63187-521bupropionbupropion
65841-780bupropionbupropion
65841-836bupropionbupropion
70934-151bupropionbupropion
63629-8036bupropionbupropion
68788-7283bupropionbupropion
68071-5214bupropionbupropion
70518-2641bupropionbupropion
51655-357bupropionbupropion
71335-1622bupropionbupropion
0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
0185-0410Bupropion HydrochlorideBupropion Hydrochloride
0185-0415Bupropion HydrochlorideBupropion Hydrochloride
0185-1111Bupropion HydrochlorideBupropion Hydrochloride
0173-0135WELLBUTRINbupropion hydrochloride
0173-0722WELLBUTRINbupropion hydrochloride
0173-0947WELLBUTRINbupropion hydrochloride
0173-0556ZYBANbupropion hydrochloride
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.